logo
logo

Nucleus Radio Pharma Appoints Dr. Stephen Hahn As Chief Executive Officer

Aug 20, 2025•3 days ago

Position

Chief Executive Officer

Company

Nucleus RadioPharma

Stephen M. Hahn
DavidsonBiotechnologyHealth CareManufacturing

Description

Nucleus RadioPharma has announced the appointment of Dr Stephen M. Hahn as their new CEO. His extensive experience in regulatory, clinical, and operational leadership is expected to enhance the company's ability to scale access to radiopharmaceutical therapies.

Company Information

Company

Nucleus RadioPharma

Location

Davidson, North Carolina, United States

About

Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months